The Neuroendocrine Tumor Drug Market size is expected to grow at an annual average of CAGR 8% during the forecast period (2024-2031). Neuroendocrine tumors (NETs) are a diverse group of neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. These tumors can occur throughout the body but are most commonly found in […]
